Wartime toxin exposure: recognising the silent killer
- 1Department of General Surgery, Sinai Hospital of Baltimore, Baltimore, Maryland, USA
- 2Department of Surgery, Sinai Center for Geriatric Surgery, Baltimore, Maryland, USA
- 3Department of Surgical Oncology, Alvin and Lois Cancer Institute, Sinai Hospital of Baltimore, Baltimore, Maryland, USA
- Correspondence to Dr Kamran Khan,
- Accepted 11 October 2016
- Published 1 December 2016
Wartime toxin exposures have been implicated in the genesis of malignancy in war veterans. Agent Orange, one toxin among many, has been linked to malignancy and the subcomponent phenoxyacetic acid has been associated with soft tissue sarcomas (STSs). This case demonstrates the association between a wartime toxin exposure (Agent Orange) and subsequent cancer development. Ultimately, we aim to highlight the importance of simple, specific questions in the patient history to account for previous wartime toxin exposures.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.